NASDAQ:NTLA charts & data provided by TradingView

Latest Insights on NTLA

gene editing biotech This Gene-Editing Stock Doubled in 3 Days
by Steve Fernandez July 6, 2021 Investment Opportunities, Technology, Winning Investor Daily
Gene editing aims to cure diseases by replacing faulty genes with the healthy variant. That means no more monthly trips to the doctor.
Weird science Intellia therapeutics biotech meme small Intellia-gent Investing, Tesla’s Not-A-Recall & Binance Schminance
by Joseph Hargett June 28, 2021 Great Stuff
Wall Street’s Weird Science ♫ From my heart and from my hand, why don’t people understand … my intentions? ♫ Great Ones, did you see what happened in the biotech market today? Holy cow … it was poetry in motion. Intellia Therapeutics (Nasdaq: ) skyrocketed more than 50% after early trial data showed the company’s […]
Name Brands in Technology Name Brand Tech Stocks Are More Profitable for Your Portfolio
by Charles Mizrahi August 15, 2019 American Investor Today, Investment Opportunities, Technology
Name brands are struggling to keep consumers’ loyalty. People opt for store or private-label brands that offer the same, if not better, quality than name brands at a better price. But there’s one sector where name brands still drive sales and revenue. Charles Mizrahi sees huge gains coming from name brands in this industry. (6-minute read)
Civil forfeiture is one of the most serious assaults on what remains of private property rights in America today, and you too could be a target. Forfeiture Reborn? Police Partner for Plunder
by Bob Bauman August 2, 2017 Wealth Confiscation
Civil forfeiture is one of the most serious assaults on what remains of private property rights in America today, and you too could be a target.
Civil Forfeiture What’s Yours Is Theirs What’s Yours Is Theirs
by Ted Bauman January 16, 2017 Wealth Confiscation
Federal civil forfeiture proceeds rocketed 4,155% between 1986 and 2013. And it could get much worse if Trump gets his wish for U.S. attorney general.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Loving this. Should have started a long time ago.”

- Jay

"You have done once again!! You are reminding me of the GREAT Joe DiMaggio with your consistent hitting!! You knocked this one out of the park!"

- Keith S.

“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”

- Larry K.

Share This